Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M
Department of Gynaecology, St Luc's University Hospital, Brussels, Belgium.
Hum Reprod. 1998 Jun;13(6):1686-90. doi: 10.1093/humrep/13.6.1686.
Angiogenesis is likely to be involved in the pathogenesis of endometriosis. According to the transplantation theory, when the exfoliated endometrium is attached to the peritoneal layer, the establishment of a new blood supply is essential for the survival of the endometrial implant and development of endometriosis. From the known angiogenic factors, vascular endothelial growth factor (VEGF) has emerged as a pivotally important regulator of normal angiogenesis and pathological neovascularization. The VEGF protein was evaluated immunohistochemically in the eutopic endometrium of 10 women without endometriosis (group I) at laparoscopy and the eutopic endometrium and peritoneal endometriotic lesions of 43 women with endometriosis (group II). VEGF histological scores were 9.7 +/- 4.3 and 4.0 +/- 2.6 respectively in the epithelium and stroma of the eutopic endometrium of group I women, and 10.3 +/- 2.3 and 3.6 +/- 2.3 respectively in women of group II. In red lesions, the VEGF scores were 11.1 +/- 3.0 in the epithelium and 5.1 +/- 3.0 in the stroma, and in black lesions were 8.6 +/- 2.7 and 1.6 +/- 1.6, respectively. Significantly lower values were observed in black lesions as compared with eutopic endometrium and red lesions, the values of which were similar. Scores were also evaluated according to the phase of the cycle. In eutopic as well as ectopic endometrium, no significant cyclic variations were observed throughout the cycle. However, VEGF content was found to be higher in the eutopic glandular epithelium of women with endometriosis during the late secretory phase, possibly suggesting a more likely tendency to implant. In contrast, significantly higher VEGF content was noted in red lesions as compared with black lesions. During all phases of the cycle, the VEGF content in stromal cells of red lesions was higher than in black lesions. Similarities in VEGF content were observed in the glandular epithelium of the eutopic endometrium of women with endometriosis and red lesions, suggesting that endometriosis probably arises from the peritoneal seeding of viable endometrial cells during retrograde menstruation and that red lesions can be considered as the first stage of implantation. After the attachment phase, the high VEGF levels could provoke an increase in the subperitoneal vascular network and facilitate implantation and viability in the retroperitoneal space. Lower VEGF levels in black lesions explain the decrease in both stromal vascularization, followed by fibrosis and inactivation of the implant.
血管生成可能参与了子宫内膜异位症的发病机制。根据移植理论,当剥脱的子宫内膜附着于腹膜层时,建立新的血液供应对于子宫内膜植入物的存活和子宫内膜异位症的发展至关重要。从已知的血管生成因子来看,血管内皮生长因子(VEGF)已成为正常血管生成和病理性新生血管形成的关键重要调节因子。在腹腔镜检查时,对10名无子宫内膜异位症女性(I组)的在位子宫内膜以及43名有子宫内膜异位症女性(II组)的在位子宫内膜和腹膜子宫内膜异位病变进行了VEGF蛋白的免疫组织化学评估。I组女性在位子宫内膜上皮和基质中的VEGF组织学评分分别为9.7±4.3和4.0±2.6,II组女性分别为10.3±2.3和3.6±2.3。在红色病变中,上皮中的VEGF评分为11.1±3.0,基质中为5.1±3.0;在黑色病变中,分别为8.6±2.7和1.6±1.6。与在位子宫内膜和红色病变相比,黑色病变中的值明显较低,而后两者的值相似。还根据月经周期阶段对评分进行了评估。在在位和异位子宫内膜中,整个周期均未观察到明显的周期性变化。然而,发现子宫内膜异位症女性在分泌晚期在位腺上皮中的VEGF含量较高,这可能表明植入的可能性更大。相比之下,红色病变中的VEGF含量明显高于黑色病变。在月经周期的所有阶段,红色病变基质细胞中的VEGF含量均高于黑色病变。在子宫内膜异位症女性的在位子宫内膜腺上皮和红色病变中观察到VEGF含量相似,这表明子宫内膜异位症可能源于逆行月经期间有活力的子宫内膜细胞的腹膜种植,并且红色病变可被视为植入的第一阶段。在附着阶段之后,高VEGF水平可促使腹膜下血管网络增加,并促进在腹膜后间隙的植入和存活。黑色病变中较低的VEGF水平解释了基质血管化的减少,随后是植入物的纤维化和失活。